Titlebook: Nanotherapy for Brain Tumor Drug Delivery; Vivek Agrahari,Anthony Kim,Vibhuti Agrahari Book 2021 Springer Science+Business Media, LLC, par

MOTE

書目名稱Nanotherapy for Brain Tumor Drug Delivery影響因子(影響力)




書目名稱Nanotherapy for Brain Tumor Drug Delivery影響因子(影響力)學(xué)科排名




書目名稱Nanotherapy for Brain Tumor Drug Delivery網(wǎng)絡(luò)公開度




書目名稱Nanotherapy for Brain Tumor Drug Delivery網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Nanotherapy for Brain Tumor Drug Delivery被引頻次




書目名稱Nanotherapy for Brain Tumor Drug Delivery被引頻次學(xué)科排名




書目名稱Nanotherapy for Brain Tumor Drug Delivery年度引用




書目名稱Nanotherapy for Brain Tumor Drug Delivery年度引用學(xué)科排名




書目名稱Nanotherapy for Brain Tumor Drug Delivery讀者反饋




書目名稱Nanotherapy for Brain Tumor Drug Delivery讀者反饋學(xué)科排名

irreparable

Drug Delivery Approaches and Imaging Techniques for Brain Tumor,ention (EPR) effect, cell-penetrating peptides (CPP), ligand-mediated delivery, etc. have been discussed briefly to overcome the BBB and its advantages and limitations including other delivery system such as vaccines, stem cell therapy, etc. However, the main focus of this book chapter is on nanopar

放縱

Surface-Modified Nanodrug Carriers for Brain Cancer Treatment,ace molecules, including the fibroblast growth factor-inducible 14 (Fn14) receptor, employed for targeting nanodrug carriers to GBM. Importantly, we review an advanced nanotherapeutic formulation developed by our team designed for optimal (1) brain tumor accumulation and penetration by reducing nons

SOBER

Strategies to Enhance the Distribution of Therapeutic Nanoparticles in the Brain by Convection Enha within healthy and tumor-bearing brains. In this book chapter, we first briefly overview the mechanism and current limitations of CED, as well as strategies to maximize the CED-mediated therapeutic and/or NP delivery to the brain. We then describe a detailed methodology for preclinical CED experime

衰弱的心

Indicative

prolate

seduce

尊重

假裝是你